Microbiology & Pathology

RICCA Chemical Company LLC is a laboratory chemical supplier serving clinical, environmental, and production laboratory markets. The company manufactures and distributes a comprehensive line of chemicals, calibration standards, and certified reference materials (CRMs) designed to meet stringent analytical and quality-control requirements. Product offerings include pH buffer solutions, conductivity standards, ion chromatography (IC) standards, and PFAS (per- and polyfluoroalkyl substances) certified reference materials. RICCA emphasizes tight specifications and minimal lot-to-lot variability as competitive differentiators. The company holds ISO 9001:2015 certification for quality management and maintains ISO/IEC 17025 and ISO Guide 17034 accreditations for reference material production and testing laboratory competence. These accreditations underscore compliance with international standards for analytical measurement and traceability. RICCA serves laboratories requiring calibration standards for environmental testing, food safety, water quality analysis, and instrument calibration across multiple analytical techniques. The company offers custom chemical solutions tailored to specific instrument and application requirements. Online platforms include product search functionality, certificate-of-analysis lookup, and safety data sheet (SDS) access, supporting procurement efficiency for institutional and industrial customers.

AB Sciex LLC is a global leader in mass spectrometry and capillary electrophoresis solutions for research, clinical diagnostics, and life sciences applications. The company manufactures a comprehensive portfolio of analytical instruments including triple-quadrupole and QTOF mass spectrometers, HPLC-MS systems, and capillary electrophoresis (CE) instruments. SCIEX serves clinical diagnostic laboratories with FDA-cleared in vitro diagnostic (IVD) medical devices for routine testing; pharmaceutical and biopharmaceutical companies for drug development and biologics characterization; contract research organizations for bioanalysis; environmental and food safety testing facilities; and life science research institutions. Core product lines include the Triple Quad 7500 Plus system, ZenoTOF 7600 QTOF system, Citrine clinical IVD mass spectrometers, ExionLC front-end HPLC systems, and Intabio ZT for charge variant analysis. SCIEX OS is the company's proprietary software platform supporting Windows 11 for data acquisition, processing, and instrument control. The company emphasizes speed, sensitivity, resolution, and ease of adoption across routine and complex analytical workflows. Manufacturing and support operations span multiple global regions, with primary headquarters in Marlborough, MA, and sales/service in Redwood City, CA (Americas) and multiple EMEA locations.

Mercedes Scientific is a B2B distributor and supplier of laboratory consumables, reagents, and diagnostic supplies serving clinical and research laboratories, histology departments, and scientific institutions. The company stocks over 30,000 products across 20+ scientific disciplines and serves approximately 9,000 laboratories and 58,000 scientists. Core product categories include histology supplies (microscope slides, reagent alcohols, xylenes, neutral buffered formalin), phlebotomy equipment (BluDraw™ safety needles and multi-sample devices), specimen collection containers, laboratory reagents, chromatography columns, cell culture media, and diagnostic test cups (including drug screening panels). Mercedes Scientific maintains in-house brands including Mercedes Scientific® and resells products from major manufacturers such as BD, Fisher, Sigma-Aldrich, Globe Scientific, Healgen, Nest, Tanner Scientific, Restek, Wondfo, Diatron, and EK Industries. The company emphasizes knowledgeable, experienced sales support with hands-on histology and laboratory workflow expertise rather than automated call-center service. Distribution capabilities include bulk case quantities and specialized pre-filled or sterile specimen containers with temperature monitoring. Primary markets served include hospital laboratories, clinical diagnostic labs, dermatology practices, research institutions, and forensic testing facilities. The company offers online ordering with bulk discounts and a concierge service for custom supply list fulfillment.

STEMCELL Technologies is a life science research company that provides innovative reagents, tools, and services for cell isolation, culture, and assay applications. The company serves academic, clinical, and industrial research laboratories globally with product portfolios spanning immunology, organoid research, hematopoietic cell research, pluripotent stem cell research, cell therapy, and neuroscience research. Their offerings include specialized cell culture media, isolation reagents, and assay tools designed for specific tissue and cell types. The company maintains dedicated scientific support services and offers training programs, including GMP-compliant Human T Cell Expansion courses. STEMCELL also provides diagnostic partnerships and OEM solutions for institutions requiring customized research reagents and protocols. Manufacturing and quality capabilities support laboratory and clinical research applications. The organization operates with a stated mission of "scientists helping scientists" and emphasizes technical expertise and customer collaboration in advancing research outcomes.

MeKo Manufacturing e.K. is a contract manufacturer of precision medical components and implants for the interventional and surgical device industry. Founded in 1995, the company pioneered stent manufacturing and is now among the largest contract manufacturers of medical components globally. MeKo specializes in laser cutting, laser welding, and advanced processing of materials including stainless steel (316L, 316LVM), cobalt alloys (L605, Phynox, MP35N), nitinol (NiTi), magnesium alloys (Resoloy®), nickel-free alloys (Vasculoy®), and polymers (PolyMediX®, PLLA, PGA). The company manufactures implants for cardiology, neurology, radiology, ophthalmology, and urology applications, with product lines including metal stents, NiTi stents, hypotubes, retrieval baskets, bone nails, heart valve frames, orthopedic devices, surgical instruments, microcomponents, and drug-delivery balloon catheters. Manufacturing capabilities include CAD/CAM design, precise laser cutting (tolerances below ±5 μm), laser welding, mechanical processing, heat treatment, shape setting, electropolishing, 3D metal printing, polymer coating, marker crimping, and rapid prototyping. The company operates ISO-certified quality management with 100% visual inspection using over 100 specialized high-end microscopes and maintains ISO 8 cleanrooms (Class 100,000). MeKo offers finite element analysis (FEA) simulation services, prototype-to-series production capabilities, and operates 24/7 manufacturing. The company maintains facilities in Germany (Sarstedt, near Hannover), the USA (Bloomington, Minnesota), California, and Costa Rica.

Diagnostic Automation / Cortez Diagnostics, Inc. (DACD) is a global diagnostic test kit manufacturer founded in 1989, serving research labs, hospitals, clinical laboratories, and physicians across 168 countries. The company specializes in producing ELISA kits, rapid test kits, chemiluminescence immunoassay (CLIA) kits, serology tests, and immunofluorescence assay (IFA) kits. DACD offers both consumable diagnostic test kits and associated instruments for clinical laboratory use. The product portfolio addresses infectious disease serology, immunological testing, and general clinical diagnostics. The company emphasizes quality assurance, competitive pricing, fast shipping, and technical customer support. DACD maintains manufacturing and distribution operations from its Woodland Hills, California headquarters and distributes globally through a network of respected distributors. The company is privately held and committed to continuous innovation in diagnostic testing methodologies.

Rocky Mountain Reagents is a manufacturer and distributor of laboratory chemicals, reagents, and supplies based in Golden, Colorado. The company operates as a direct-from-manufacturer supplier of bulk chemicals with no minimum order quantities, serving laboratories, research facilities, semiconductor manufacturers, CBD processors, and forensic operations. Product offerings include: acids and bases (nitric acid, hydrochloric acid, semiconductor-grade formulations), solvents and alcohols (HPLC-grade acetonitrile, acetone, ethanol), biological stains, buffers, indicators, titrants and standards, fine chemicals, forensic reagents, heat transfer fluids, and purification/remediation media. Laboratory supplies include glassware, plasticware, nitrile gloves (Aurelia brand), and consumables. Equipment offerings span analytical instruments (OHAUS benchtop scales), extraction equipment, lab ovens, refrigeration, pumps, and cultivation equipment. The company emphasizes in-house quality control with dedicated chemists and chemical engineers, NIST-traceable products, SDS documentation, and custom blending services. Customers cite rapid turnaround (next-day pickup capability), hands-on customer service, competitive pricing, and consistent purity standards exceeding industry specifications. The company operates two related brands: 710 SCI and Pioneer Forensics, serving specialized forensic and scientific markets.

JelloX Biotech Inc. is a Taiwan-based biotech company specializing in 3D digital pathology imaging and AI-assisted diagnostic software. The company develops Metalite, a proprietary 3D pathology analysis software platform integrated with artificial intelligence modules designed to support precision medicine diagnostics. Metalite assists pathologists in evaluating clinical tissue specimen morphology variations and identifying tumor-targeted molecular distribution patterns, thereby enhancing cancer diagnosis accuracy and supporting new drug development workflows. The company positions itself as a pioneer in 3D intelligent pathology, leveraging innovative technology to enable precise medical diagnosis and treatment planning. JelloX markets its solutions internationally, collaborating with renowned hospitals and healthcare institutions to expand its global presence. The company emphasizes rigorous scientific validation and quality compliance as core values, with a commitment to building an integrated ecosystem of digital pathology and AI-enabled medical solutions. Services include 3D pathological image analysis and cancer cell detection support for clinical laboratories and research institutions.

ELITechGroup is a global in-vitro diagnostics (IVD) manufacturer serving hospitals and diagnostic laboratories in over 100 countries. Owned by Bruker Corporation, the company develops, manufactures, and distributes diagnostic instruments, reagents, and software across three specialized business divisions: Molecular Diagnostics (MDx), Biomedical Systems (EBS), and Microbiology (EM). With approximately 600 global professionals, ELITechGroup addresses laboratory diagnostic needs including molecular testing, clinical chemistry, immunoassay, and microbiology analysis. The company operates as part of Bruker Microbiology & Infection Diagnostics division (BMID), combining advanced diagnostic technologies with sample-to-result automation and high-throughput instrumentation. Products serve clinical laboratories, hospital diagnostics departments, and reference laboratories requiring FDA-cleared and CE-marked diagnostic solutions. The company maintains regional sales offices across North America, Europe, Australia/New Zealand, and Asia-Pacific.

US BioTek Laboratories is a functional and integrative medicine diagnostic laboratory specializing in precision testing for naturopathic doctors, functional medicine practitioners, and integrative healthcare providers. The company operates a CLIA-certified and CAP-accredited laboratory offering comprehensive testing panels across six primary areas: Food Sensitivity Testing (IgG antibody assessment), GI Microbiome Testing (bacterial composition and metabolite analysis), Environmental Toxin Testing (mycotoxins, glyphosate, and pollutant detection), Food Allergy Testing (IgE antibody profiling), Organic Acids Testing (metabolic markers including NAD/NADH), and Hormone Testing (steroid and other hormonal markers). Their VeriTek™ quality assurance methodology emphasizes automated systems, superior assay preparation, duplicate testing protocols, and external accreditation to ensure reproducible results. The company provides collection kits with prepaid return shipping, rapid turnaround times, and results delivery via a provider portal. US BioTek serves the functional medicine and naturopathic medicine markets and recently completed a merger with NutriPATH Pathology to expand service offerings. The laboratory is positioned for practitioners seeking specialty diagnostic tools to guide precision treatment recommendations and is particularly utilized in anti-aging medicine, gastrointestinal health assessment, hormone optimization, and environmental toxicology.

ML LifeSciences is a contract manufacturer specializing in custom sterile reagents and media for clinical, diagnostic, biotech, veterinary, and quality control laboratory applications. The company offers terminal sterilization, aseptic fills, universal transport media, and compounded reagents across traditional and emerging formulations. Manufacturing capabilities span the full product lifecycle: raw material sourcing, formulation, sterile manufacturing, and packaging in client-specified containers including syringes, transport vials, tubes, PVC and EVA solution bags, and polycarbonate bottles. The company serves clinicians, researchers, laboratory professionals, and diagnostic laboratories with custom solutions for QC, diagnostic, biotech, and veterinary applications. ML LifeSciences is ISO 9001 certified and maintains compliance with federal and state regulatory agencies, ensuring rigorous manufacturing standards and quality control. The company emphasizes on-time delivery, consistent product quality, and superior value for demanding and time-critical projects.

Lighthouse Worldwide Solutions (LWS) manufactures environmental monitoring (EM) systems and equipment for cleanroom contamination control across pharmaceutical, semiconductor, EV battery, and data center applications. The company specializes in real-time monitoring systems (RTMS) that integrate airborne particle counters, liquid particle counters, viable microbial samplers, and environmental sensors (temperature, pressure, humidity) into integrated platforms. LWS products include the System-In-a-Box™ (plug-and-play EM control cabinets), Apex and Solair airborne particle counters, Vertex liquid particle counters, ActiveCount viable samplers, and ScanAir handheld units. The company serves ISO Class 5 and cleaner cleanrooms in aseptic pharmaceutical manufacturing, continuous microbial monitoring for Grade A environments, semiconductor manufacturing, EV battery production, and compressed gas sampling applications. LWS provides real-time data logging, environmental out-of-tolerance alerts, and contamination control solutions mandated by GMP and regulatory standards for pharmaceutical and medical device production. The company offers consulting services for EM system design and implementation and participates in industry events including SEMIExpo and semiconductor exhibitions.

Oxyrase, Inc. is a clinical microbiology laboratory supplier specializing in anaerobic culture solutions and oxidation prevention products. Founded in 1987, the company manufactures the patented Oxyrase® Enzyme System, a core technology used in pre-reduced anaerobic sterile (PRAS) media and culture plates designed to create optimal conditions for oxygen-sensitive organisms. The company's product portfolio includes OxyPRAS Plus® plates (Brucella blood agar, PEA, BBE/KVL bi-plates), OxyPlate™ systems, and Oxyrase® for Broth formulations. Beyond anaerobic microbiology, Oxyrase supplies antioxidant solutions and biological preservation products that extend shelf life of sensitive materials and protect microorganisms during cryogenic storage. Products serve hospitals, medical laboratories, research institutions, and quality control facilities. The company also provides OEM and custom formulation services for specialized applications across clinical, pharmaceutical, food quality, and research sectors.

Monobind Inc. is a leading independent in vitro diagnostics (IVD) manufacturer founded in 1978 and headquartered in Lake Forest, California. The company develops and manufactures over 160 immunoassay products across its AccuBind® ELISA and AccuLite® CLIA platforms, serving clinical laboratories, point-of-care facilities, and direct-to-patient applications globally. Monobind's portfolio spans multiple assay formats—microplate, monotest, magnetic-bead, lateral flow assays (LFA), and microarray technologies—enabling testing of serum, plasma, and whole blood samples. The company supports scalable workflows from manual reader-based systems to fully automated random-access analyzers. Beyond finished assays, Monobind supplies high-quality biomaterials and specialty reagents including buffers and stabilizers for the global diagnostics industry. Operating under FDA registration and ISO 13485 certification, the company distributes CE-marked products to laboratories and partners in over 100 countries worldwide.

Zeta Corporation is an ISO 13485:2016 and FDA-registered biomedical manufacturer specializing in precision recombinant in vitro diagnostic (IVD) antibodies for immunohistochemistry (IHC) applications. The company develops and distributes a portfolio of over 400 tumor and tissue-specific IVD recombinant antibodies designed for anatomic pathology laboratories. Zeta's product lines include MonoMAb™ monospecific mouse monoclonal antibodies and RAbMono™ rabbit monoclonal antibodies, both engineered for high specificity, sensitivity, and reproducibility on formalin-fixed, paraffin-embedded (FFPE) tissue sections. All antibodies are rigorously validated and target-verified by pathologists to ensure consistent, reliable diagnostic results. With over 75 years of collective scientific expertise, Zeta manufactures antibodies using recombinant production methods for rapid, reliable manufacturing and distributes directly in the United States and through trusted partners to over 50 countries worldwide.

SSI Diagnostica Group is a global leader in infectious disease clinical diagnostics, specializing in in vitro diagnostic (IVD) solutions, reagents, antisera, and quality control products. With ~600 employees across Denmark, the United States, and China, the company delivers diagnostic solutions in over 130 countries annually, serving more than 60 million people. Founded as a division of Denmark's Statens Serum Institut in the early 1900s and privatized in 2016, SSI Diagnostica now operates as a unified group comprising five portfolios: SSI Diagnostica, TECHLAB, Beijing Genesee Biotech, CTK Biotech, and Gulf Coast Scientific, combining over 200 years of combined scientific expertise. The company focuses on gastrointestinal, respiratory, bloodborne, and general microbiology diagnostics, providing rapid diagnostic tests, outbreak investigation support, and disease surveillance solutions for reference laboratories, hospitals, and healthcare professionals worldwide.

Screentec Oy is an ISO 13485-certified contract development and manufacturing organization (CDMO) specializing in printed electronics for medical devices and diagnostics. Founded in 1989 with over 35 years of regulated manufacturing experience, Screentec delivers end-to-end product commercialization services from concept design and R&D prototyping through mass production. The company manufactures wearable medical sensors, disposable ECG electrodes, diagnostic and microfluidic devices, point-of-care platforms, electrochemical sensors, and user interfaces for medical, industrial, and IoT applications. Screentec maintains full vertical integration—design, material conversion, process engineering, regulatory affairs—and complies with FDA 21 CFR Part 820, EU MDR, IVDR, and IEC 60601 standards. The company serves demanding healthcare environments, diagnostic device manufacturers, and industrial sectors requiring high-reliability flexible electronics and sensor solutions.

True Indicating LLC is a sterilization and disinfection technology innovator established in 2017, specializing in customized biological and chemical indicators for healthcare, dental, pharmaceutical, industrial, and life science applications. Based in Toledo, Ohio, the company combines over 35 years of combined expertise in microbiology and healthcare technology to develop indicators for traditional sterilization modalities (steam, ethylene oxide, hydrogen peroxide, dry heat, irradiation, formaldehyde, chlorine dioxide) and emerging technologies. True Indicating manufactures biological indicators (BIs), self-contained BIs (SCBIs), inoculated carriers, chemical indicator inks, tapes, integrators, and emulators. The company offers on-site inoculation, propagation of custom organisms, resistance verification testing, sterilization process validation, and consulting services. FDA-registered and ISO 13485:2016 certified, True Indicating provides scaled production with in-house manufacturing infrastructure and serves thousands of healthcare customers requiring quality sterilization assurance and compliance solutions.

Verax Biomedical manufactures the Platelet PGD prime®, an FDA-cleared rapid diagnostic test for bacterial contamination detection in blood platelets. The test enables extended 7-day platelet dating, addressing FDA guidance on bacterial risk mitigation in blood collection establishments. The platform uses immunoassay technology to detect bacterial cell wall antigens, including enhanced Acinetobacter species detection, providing visual result interpretation without complex sample pretreatment. Designed for blood banks and transfusion services, the test reduces blood product outdate, improves platelet availability, and delivers cost savings through extended dating protocols. The company provides online training and supports FDA compliance for blood safety diagnostics.

ENG Scientific, LLC is a B2B manufacturer and supplier of clinical laboratory stains and reagents serving hospitals, diagnostic laboratories, doctor offices, and private clinics since 1976. The company specializes in histology stains, microbiology stains, hematology reagents, cytology solutions, and specialized staining kits for tissue preparation and microbial identification. Product portfolio includes Wright-Giemsa stains, Gram stain kits, Hematoxylin stains, iron staining solutions, and buffer systems used across clinical pathology, cytopathology, hematology, and microbiology departments. ENG Scientific supplies both individual reagent solutions and complete stain kits in various volumes, serving the quality control and diagnostic needs of clinical laboratory professionals.

Illumina, Inc. is a global leader in DNA sequencing and array-based genomic analysis, providing comprehensive solutions for research, clinical diagnostics, and precision health applications. The company manufactures next-generation sequencing (NGS) platforms ranging from benchtop to production-scale instruments, microarray systems for genetic analysis, and library preparation kits optimized for diverse DNA and RNA workflows. Illumina's product portfolio includes the TruPath Genome solution, Single Cell 3' RNA Prep kits, and associated bioinformatics software for data analysis and insights. The company serves academic research institutions, clinical laboratories, pharmaceutical companies, and healthcare providers globally, enabling applications in cancer research, genetic disease testing, infectious disease surveillance, reproductive health, and precision medicine. Illumina offers 24/7 technical support, comprehensive documentation, training resources, and multiple financing options for instrument acquisition. The company maintains regulatory compliance with FDA clearances and international standards, and provides worldwide distribution through channel partners and direct sales. Corporate headquarters located in San Diego, CA with regional offices and support centers across North America, Europe, Asia-Pacific, and other global markets.

MediBeacon Inc. is a medical technology company specializing in fluorescent tracer agents and transdermal detection technology for non-invasive physiological monitoring. The company's proprietary platform enables real-time measurement and monitoring of vital organ function through biocompatible fluorescent agents that are sensed through the skin via transdermal optical sensors. Primary clinical focus areas include nephrology (kidney function assessment via transdermal GFR measurement), gastroenterology (gut barrier permeability assessment), ophthalmology (fluorescent angiography for retinal vasculature visualization), and surgical applications (intraoperative visualization and identification of anatomical structures). MediBeacon's Transdermal GFR (TGFR) System received FDA PMA approval (P230019) and CE Mark for human clinical use. The company serves leading academic medical centers, research institutes, contract research organizations (CROs), and pharmaceutical companies globally for both preclinical research and clinical applications. MediBeacon maintains offices in St. Louis, Missouri (USA), Mannheim, Germany, and partnerships in Greater China through Huadong Medicine Co., Ltd.

Morphle Labs Inc. is an AI-enabled health tech company specializing in digital pathology and cancer diagnostics automation. The company develops robotic whole slide scanners, robotic microtomes, and intelligent image management systems designed to enhance pathology lab workflows. Their product portfolio addresses tissue preparation, high-throughput slide scanning, AI-driven image analysis, and digital archiving. The MorphoLens scanner family (240, 6, 1 variants) and HemoLens platform serve anatomical pathology, dermatopathology, hematology, and cytology applications. Morphle's solutions enable telepathology, reduce turnaround time, improve diagnostic accuracy, and support research institutions and cancer hospitals globally. The company holds 25+ patents and emphasizes superior image quality, LIS integration, and compact data storage formats.

Steritec Services LLC is a contract sterilization and biological testing provider specializing in medical device processing. The company operates a 54,000 square foot facility in Athens, Texas, equipped with ethylene oxide (EO) and steam sterilization chambers, along with comprehensive chemical and biological testing laboratories. Core services include 100% ethylene oxide sterilization, steam sterilization, sterility testing, LAL endotoxin analysis, EO residuals testing, and bioburden assessment. The company serves medical device manufacturers requiring validated sterilization processes and regulatory-compliant testing support, including ISO 11135 process validation, biological indicator testing, and process validation documentation. Steritec also provides professional consulting guidance for regulatory compliance and sterilization program development.

Avails Medical, Inc. is an in vitro diagnostics company founded in 2013 by Stanford University alumni and based in Menlo Park, California. The company specializes in rapid, automated antibiotic susceptibility testing (AST) technologies aimed at addressing antimicrobial resistance and improving outcomes for sepsis patients. Their innovative all-electrical biosensor platform streamlines the testing process by eliminating manual culturing steps, allowing for faster pathogen quantification and susceptibility testing directly from human specimens. The flagship product, the eQUANT™ System, is an FDA-cleared electronic biosensor that provides results in approximately 70 minutes, significantly reducing turnaround time for testing common gram-negative bacteria. This system is designed for easy integration into laboratory workflows and supports timely diagnostics, which can lead to better patient outcomes and lower healthcare costs. Each minute of diagnostic delay increases sepsis mortality risk; Avails Medical's rapid AST platform addresses the critical clinical need for accelerated antimicrobial susceptibility identification in blood culture specimens, with documented multicenter validation.

Microbiologics is a leading provider of biological reference materials, quality controls, and contract research organization (CRO) services for microbiology, molecular diagnostics, and virology. Founded over 50 years ago and headquartered in Saint Cloud, Minnesota, the company serves healthcare and life science laboratories, diagnostic manufacturers, and biopharmaceutical companies globally. In microbiology, Microbiologics offers the industry's largest collection of reference strains in ready-to-use formats including KWIK-STIK™, EZ-Accu Shot™, Epower™, and LYFO DISK™ products for quality control of growth promotion testing, enumeration methods, and antimicrobial effectiveness testing. The company provides custom microbiology services including environmental isolate controls, antimicrobial assays, microbiome testing, and proficiency testing solutions. In molecular diagnostics, Microbiologics manufactures external third-party IVD quality controls and reference standards under the Helix Elite™ brand for infectious disease diagnostics (respiratory, STI/women's health, gastrointestinal, healthcare-associated infections) and oncology (gDNA, cfDNA/ctDNA, FFPE). Virology capabilities include BSL-2 and BSL-3 contract research laboratories offering custom and off-the-shelf viral stocks, recombinant virus production, adventitious virus panels, viral assay development, and antiviral drug and vaccine testing services. The company maintains ISO 17025 accredited facilities and provides certified reference materials (CRM) for regulated laboratory environments. Microbiologics serves IVD manufacturers, pharmaceutical companies, clinical diagnostic laboratories, and research institutions across North America, Europe, and globally.

AnalytiChem is a specialized manufacturer of laboratory chemicals, certified reference materials (CRMs), and custom reagents serving pharmaceutical, environmental, food, chemical, and microbiology industries. Operating since 1972 (as Bernd Kraft GmbH, rebranded in December 2022), the company manufactures over 10,000 ready-to-use laboratory chemical products with ISO 17025 accreditation and DIN ISO 17025 certified testing laboratory. They provide ultra-high-purity acids, multi-element standards, ICP/AAS reagents, and prepared culture media with customizable packaging and pre-measured dosing. AnalytiChem prioritizes workplace safety by formulating hazardous raw materials into safer solutions, reducing waste through pre-mixed formulations, and ensuring regulatory compliance with current chemical classification standards and safety data sheets. The company operates multiple European manufacturing sites and offers on-site consulting through qualified field service teams.

Novex Innovations is a contract development and manufacturing organization (CDMO) specializing in the design, development, and commercialization of biologics, pharmaceuticals, medical devices, and bioengineered tissue. Operating a 36,000 square-foot cGMP-compliant facility with Class 100 and Class 1,000 cleanroom spaces, the company provides comprehensive services spanning product and process development, clinical and commercial manufacturing, regulatory support, and distribution. Capabilities include biological formulations, clinical formulation, tissue processing, active pharmaceutical development, diagnostic materials manufacturing, and inventory management. ISO 13485 certified and FDA-registered, Novex supports clients from proof-of-concept through all phases of clinical trials to commercial scale-up and market distribution, serving both startups and multinational organizations across national and international markets.

Becton, Dickinson and Company (BD) is a global medical technology leader founded in 1897 with approximately $20.2 billion in FY2024 revenue. BD supplies a comprehensive portfolio spanning diagnostic and laboratory solutions, surgical products and instruments, medication management systems, and infection prevention technologies. The company pioneered disposable syringes (Plastipak™) and blood collection systems (BD Vacutainer®), and operates automated blood culture and diagnostic platforms. Through strategic acquisitions including CareFusion and C.R. Bard, BD expanded capabilities in medication management, surgical interventions, and hospital systems. Current offerings address ambulatory surgery centers, diagnostic accuracy and specimen collection workflows, patient safety and infection control, advanced clinical analytics through BD HealthSight Advisor, medication management optimization, and surgical efficiency. BD Incada™ Connected Care Platform represents the company's digital health integration strategy. With global operations across alternate sites, diagnostic labs, research areas, hospital units, pharmacy, and surgical suites, BD serves healthcare systems seeking integrated solutions to improve patient outcomes and operational efficiency.

TheraTest Labs delivers tailored in-practice diagnostic laboratory solutions focused on autoimmune disease testing and monitoring. The company provides a comprehensive platform combining specialist immunoassays, automated analyzers, and expert support services designed to help medical practices implement compliant in-house labs while maximizing revenue. With three decades of experience, TheraTest enables practices to offer timely diagnosis, prognosis, and therapeutic monitoring of autoimmune conditions through multiplex assays and cutting-edge diagnostic instrumentation. Their expert team ensures CLIA compliance and operational excellence, helping practices enhance net revenue by an average of $60k–$100k per provider annually.

TECHLAB, Inc. is a leading developer, manufacturer, and distributor of rapid, non-invasive diagnostic tests for gastrointestinal and infectious diseases. Founded in 1989 and headquartered in Blacksburg, Virginia, with manufacturing operations in Radford, Virginia, TECHLAB specializes in point-of-care and laboratory diagnostics for enteric pathogens, respiratory infections, and intestinal inflammation markers. The company's proprietary QUIK CHEK® technology delivers accurate results in under 30 minutes. Product portfolio includes rapid diagnostic assays for C. difficile (including toxin detection), foodborne pathogens (E. coli, Shiga toxin), parasitic infections, H. pylori, fecal biomarkers of intestinal inflammation (lactoferrin), and respiratory pathogens (S. pneumoniae, L. pneumophila). All products are manufactured in the United States under ISO MDSAP certification and FDA registration. TECHLAB also provides contract manufacturing and contract research services for diagnostic product development. With approximately 144–150 employees and annual revenue of $23.7 million, the company distributes diagnostics globally to clinical laboratories, hospitals, and healthcare providers.

Q.I. Medical manufactures specialized products for pharmacists, nurses, and pharmacy technicians handling sterile solutions. The company focuses on devices, test kits, and accessories that improve aseptic technique and validate compliance with USP Chapters 795, 797, 800, and 71. Product applications include environmental monitoring and surface sampling, gloved fingertip testing, sterility and endotoxin testing, TPN process validation, media fill testing for aseptic technique validation, incubation systems, and needleless dispensing solutions. Q.I. Medical serves institutional pharmacy and compounding operations requiring documented quality assurance and regulatory compliance.

BioPorto Diagnostics A/S is a Denmark-based in vitro diagnostics company specializing in kidney health biomarkers for early detection of acute kidney injury (AKI). The company develops and manufactures clinical diagnostic tests, ELISA kits for research applications, monoclonal antibodies, and rapid assays targeting nephrology and critical care markets. BioPorto's flagship product, the NGAL Test™, is CE-marked for EU clinical use and FDA-cleared for pediatric AKI risk assessment in the US. The NGAL biomarker enables early identification of kidney damage, potentially preventing irreversible injury and guiding timely clinical intervention. BioPorto also supplies human and animal NGAL ELISA kits for preclinical and Phase 1 clinical research. The company collaborates with major diagnostic manufacturers including Roche Diagnostics and Siemens Healthcare to distribute products via clinical chemistry analyzers and laboratory platforms. With deep expertise in assay development and monoclonal antibody production, BioPorto serves hospitals, clinical laboratories, research institutions, and pharmaceutical companies focused on improving kidney care outcomes.

RTsafe is a medical technology company specializing in quality assurance solutions for radiation oncology and stereotactic radiosurgery. The company develops patient-specific anatomical phantoms using advanced 3D printing technology based on patient CT scans to enable precise dosimetry verification and pretreatment quality assurance. RTsafe's flagship product, the FDA-cleared PseudoPatient®, replicates individual patient anatomy for accurate dose measurement and treatment planning validation. The company also offers the Prime Phantom for linear accelerator quality assurance, the SBRT Phantom for abdominal stereotactic body radiotherapy planning, customized phantom services, and remote dosimetry audit services. RTsafe's solutions support radiation oncologists, medical physicists, and treatment centers globally in achieving minimum-achievable-risk radiotherapy through rigorous end-to-end treatment chain validation.

BUHLMANN Diagnostics Corp is a clinical laboratory diagnostic company specializing in immunoassay and biochemical testing solutions. The company manufactures and distributes FDA-cleared in vitro diagnostic (IVD) assays across multiple therapeutic and diagnostic areas including gastroenterology, autoimmunity, cellular allergy, neuroimmunology, clinical chemistry, and chronobiology. Core product lines include calprotectin assays (BÜHLMANN fCAL® turbo and ELISA), pancreatic elastase (BÜHLMANN fPELA® turbo), Quantum Blue® point-of-care and laboratory immunoassay systems, Flow CAST® and CAST® ELISA for allergy testing, and neuroimmunology assays for peripheral neuropathy detection (GanglioCombi® MAG and anti-ganglioside antibody tests). The company offers random-access turbidimetric immunoassays, ELISA-based methods, and extraction technologies (CALEX® Cap) for improved analytical stability and laboratory workflow automation. FDA clearance is documented for multiple products including fCAL® turbo, fCAL® ELISA, fPELA® turbo, ACE KINETIC, and CIC-C1q ELISA. BUHLMANN serves clinical laboratories, hospital pathology departments, gastroenterology centers, and specialty diagnostic facilities. The organization maintains quality management systems and actively participates in medical and scientific conferences (e.g., DDW 2026). Support includes technical customer service, FAQs, and product-specific literature.

Greiner Bio-One International GmbH is a global manufacturer of biotechnology, diagnostics, and medical device solutions serving clinical laboratories, research institutions, and in vitro diagnostics markets. With headquarters in Kremsmünster, Austria, and a US presence, the company operates 28 subsidiaries and manufacturing sites across Austria, Germany, Hungary, the United States, Brazil, and Thailand, employing over 2,300 staff. The company specializes in preanalytical and bioanalytical solutions, including venous and capillary blood collection systems, urine collection containers, and safety blood collection devices. Their VACUETTE® EVOPROTECT line represents next-generation safety blood collection technology. Greiner Bio-One also manufactures comprehensive laboratory consumables: sterile syringes, needles, IV sets, collection tubes, and sample handling equipment. In bioscience research, they supply cell culture products (including 3D magnetic cell culture solutions), microplates, cryopreservation systems, and high-throughput screening (HTS) imaging microplates designed for drug discovery and ADME studies. Their portfolio includes specialized products for mass cell culture and advanced research applications. The company emphasizes safety, quality, and sustainability; they have achieved ACT Ecolabel certification for over 127 products, reflecting eco-conscious manufacturing. Greiner Bio-One serves research laboratories, clinical diagnostics facilities, blood banks, and pharmaceutical/biotech companies globally. The organization maintains strong regulatory compliance and participates actively in international scientific conferences and laboratory diagnostic forums.

IMMCO Diagnostics is a clinical reference laboratory located in Buffalo, NY, specializing in serological and biopsy testing for autoimmune diseases and pregnancy-related complications. Licensed throughout the United States, the company offers diagnostic testing for Sjögren's syndrome, Rheumatoid Arthritis, Celiac Disease, Ulcerative Colitis, Crohn's Disease, Systemic Lupus Erythematosus, and Scleroderma. The laboratory is known for developing proprietary biomarkers, including novel SP-1, CA-6, and PSP markers for Sjögren's syndrome that increase diagnostic sensitivity above 80% before traditional antibodies appear. IMMCO also provides preeclampsia risk assessment testing using FDA-cleared biomarkers (sFlt-1 and PlGF) with KRYPTOR instrumentation to guide early clinical intervention and reduce maternal-fetal complications. The company was co-founded by periodontists and maintains specialized Oral and Maxillofacial pathology services with over 40 years' experience; staff includes board-certified oral and immune pathologists offering case consultations and second opinions. Services include individual tests, panels, genetic testing for autoimmune conditions, and family screening. The laboratory operates as a reference service provider, accepting specimens from healthcare providers nationwide.

Simport Scientific Inc. is a developer and designer of consumable and reusable laboratory products founded in 1975. The company manufactures and distributes more than 2,000 items across five continents, specializing in specimen handling, histology, cytology, PCR, and general laboratory consumables. Product portfolio includes PCR plates (96-well low-profile, skirted and non-skirted formats), histology cassettes (embedding, biopsy containers with lateral vents for tissue access), cytology funnels, cryopreservation products, microtubes with snap and screw caps, specimen bottles, reagent reservoirs, sterile sampling bags, and general labware. Signature product lines include SuperFlex™ PCR plates, CoreDish® biopsy containers, SuperFlo™ micro-biopsy cassettes, ClikLok™ tubes, and Twirl'em™ sterile sampling bags. Products are formulated to be RNase, DNase, Pyrogen, and DNA-free; manufactured from virgin polypropylene or polystyrene; and designed for compatibility with automated laboratory systems and centrifugation. Many products are autoclavable, gamma-irradiated capable, and meet USDA and ACIA industry standards. The company serves clinical, research, and diagnostic laboratories with reliable, quality consumables designed for modern laboratory workflows.

Getinge is a global medical technology company with over a century of heritage, serving healthcare systems, surgical teams, and research laboratories worldwide. The company designs and manufactures critical care equipment, operating room systems, cardiovascular procedure devices, sterile reprocessing systems, and digital health solutions. Core product portfolios include the Servo mechanical ventilation systems (including Servo-air Lite for non-invasive ventilation and ICU-grade ventilators), Maquet surgical lighting and operating room equipment, cardiovascular intervention devices, sterilization and reprocessing equipment for surgical instruments, and pharmaceutical production systems. Getinge serves intensive care units, operating rooms, cardiovascular catheterization labs, sterile processing departments, pharmaceutical manufacturing facilities, and research laboratories. The company maintains a significant U.S. presence and participates in major medical conferences (SCAI, PAS, AATS, HSPA, Muse). Products are designed for personalized patient care with emphasis on clinical outcomes, ease of use, and regulatory compliance. Getinge operates across multiple healthcare sectors including critical care ventilation, surgical support, infection control, and digital health platforms for hospital operations.

BioGenex Laboratories is a US-based manufacturer of in vitro diagnostic instruments, reagents, and detection kits for immunohistochemistry (IHC), in situ hybridization (ISH), fluorescent in situ hybridization (FISH), and multiplex molecular diagnostics. The company serves pathology laboratories, research institutions, and clinical diagnostics centers globally, with offices in Fremont (CA), India, and China. BioGenex produces a comprehensive portfolio of automated staining instruments (Xmatrx® Elite, i6000™, NanoVip™, Neuvo), detection kits, monoclonal and polyclonal antibodies, ISH and FISH probes, antigen retrieval systems (EZ-RT), and ancillary reagents. Products are designed for tumor diagnosis, biomarker panel testing, and gene expression analysis on formalin-fixed, paraffin-embedded (FFPE) tissue specimens. The company offers sales support, technical support, comprehensive training programs, and field service including on-site installation, maintenance, and troubleshooting. Customer base includes major academic medical centers (Mayo Clinic, Cleveland Clinic, Stanford Healthcare, MD Anderson), national reference laboratories (Quest Diagnostics, LabCorp), and hospital systems. BioGenex maintains rigorous product testing and provides operator manuals, scientific literature, and technical documentation.

Beacon Biosignals is an AI-driven neurotechnology company specializing in clinical-grade sleep EEG capture and biomarker analysis for drug development and clinical research. The company develops FDA-cleared headband devices (Dreem 3S) that collect high-fidelity sleep electroencephalography data in home and clinical settings, paired with proprietary AI algorithms trained on 200,000+ hours of EEG recordings. Beacon's end-to-end platform supports translational research, clinical trial optimization, and real-world clinical practice across psychiatric disorders (major depressive disorder, schizophrenia, bipolar disorder), neurological conditions, and primary and secondary sleep disorders. The company provides quantitative sleep endpoints and pharmacodynamic biomarkers to identify dose-dependent drug effects, characterize and stratify patient populations, support label expansion claims, and track disease progression. Services include full-service clinical trial support with Clinical Study Operations and Scientific Services teams managing device setup, software integration, data quality assurance, and regulatory reporting. Beacon's technology enables objective measurement of sleep architecture and brain function, reducing participant and site burden compared to traditional methods. The platform integrates secure data upload, low-latency event monitoring for compliance and treatment response assessment, and analytics for cohort identification. Beacon is backed by significant venture funding (Series B upsized to $97 million+ as of April 2026) and serves pharmaceutical development, clinical research organizations, and academic institutions. Products are restricted to clinical trial, diagnostic, and academic research use and are not available for individual consumer purchase.

Gentech Diagnostics is a CLIA/COLA-certified reference laboratory providing comprehensive diagnostic testing services exclusively to healthcare providers. The company specializes in molecular testing and toxicology analysis with rapid turnaround times (24-48 hours for most results). Operating as a B2B laboratory service provider, Gentech Diagnostics does not perform direct-to-patient testing and works exclusively with ordering physicians and healthcare facilities. The laboratory is licensed to serve healthcare providers across Texas, California, and Arizona, with board-certified specialists conducting expert analysis and interpretation of test results. The company is enrolled as a Medicare and Medicaid provider and maintains HIPAA compliance, CAP accreditation, and Privacy Shield certification. Gentech Diagnostics positions itself as a trusted reference laboratory setting standards in medical diagnostics through advanced technology and professional analysis capabilities.

Trinity Biotech plc is a publicly listed clinical diagnostic products manufacturer specializing in blood analyzers, rapid immunoassays, and laboratory consumables. The company develops and markets diagnostic solutions across hematology, infectious disease, and metabolic screening. Key product lines include the Premier Resolution HPLC analyzer for hemoglobin variant and thalassemia detection; Uni-Gold HIV Complete rapid immunoassay for HIV-1/HIV-2 detection in serum, plasma, and whole blood; Bartels FlexTrans transport medium for specimen preservation; and Captia brand diagnostics. Trinity Biotech serves clinical laboratories, blood banks, and point-of-care settings globally. The company holds regulatory approvals including IFCC classification (Gold standard for HbA1c measurement on Premier Hb9210 system) and operates under offshored and outsourced manufacturing models to support supply chain efficiency. As a Nasdaq-listed entity, Trinity Biotech maintains compliance with regulatory and listing requirements, positioning itself as a supplier of high-quality, validated diagnostic instrumentation and consumables for clinical and research applications.

Salmon Medic is a comprehensive medical equipment distributor and service provider offering end-to-end solutions for hospitals, clinics, academic institutions, and veterinary facilities. The company supplies a broad range of diagnostic, surgical, laboratory, and specialized medical equipment alongside procurement, installation, staff training, and after-sales support. Product categories include endoscopy systems, surgical instruments and equipment, orthopedic devices, laboratory analyzers and tools, veterinary equipment, furniture, and IVF solutions. Additionally, Salmon Medic serves industrial and workplace safety markets with first-aid kits, protective equipment, and emergency response supplies. The company emphasizes regulatory compliance (CE/FDA certification), quality assurance through rigorous QA protocols and certified calibration, and responsive local technical support. Services encompass supply chain management, field-proven reliability, continuous technical consultation, equipment upgrades, and training programs for healthcare professionals and medical students. Markets served include academic medical centers, nursing colleges, clinical laboratories, veterinary departments, and hospital systems seeking integrated equipment solutions with transparent pricing and clear service-level agreements.

Cellay, Inc. manufactures oligonucleotide FISH (fluorescence in situ hybridization) probes for cytogenetic and molecular diagnostic applications. The company specializes in Same Day OligoFISH® Probes—short, chemically synthesized and labeled oligonucleotides designed to enumerate chromosomes with rapid hybridization kinetics (5–10 minutes at room temperature/isothermal processing). Products are manufactured under cGMP standards, supporting clinical laboratory workflows for chromosome analysis and cytogenetic testing. Cellay's probes are marketed as analyte-specific reagents (ASRs) and are covered by pending US and worldwide patent applications. The company serves clinical laboratories and research institutions requiring fast, efficient FISH probe solutions for karyotyping and chromosomal abnormality detection. Note: Same Day OligoFISH® Probes have not received FDA approval or clearance for cancer detection or diagnosis.

Sotera Health LLC is a leading global provider of mission-critical sterilization solutions, laboratory testing, and advisory services serving the healthcare, medical device, pharmaceutical, and food safety industries. The company operates through three primary business divisions: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services across 49 global facilities, offering gamma irradiation, ethylene oxide processing, electron beam irradiation, nitrogen dioxide sterilization, and X-ray irradiation technologies. Nelson Labs operates 12 facilities globally and delivers comprehensive microbiological and analytical chemistry testing services—over 900 laboratory tests—including sterilization validation, sterility assurance, and quality testing for medical devices and pharmaceuticals. Regulatory compliance consulting is provided through Regulatory Compliance Associates. Nordion supplies cobalt-60 medical gamma technology for disease prevention and treatment to pharmaceutical companies, biotechnology firms, hospitals, and research laboratories across 40+ countries. Sotera Health serves approximately 3,000 customers and is positioned as a best-in-class partner for complex testing, validation, and sterilization challenges in regulated healthcare markets.

Aiken Corporation is a Southern California-based laboratory equipment manufacturer founded in 1988. The company manufactures and exports a comprehensive range of general laboratory equipment using domestic and foreign components, serving hospitals and clinical laboratories in over 60 countries. Product lines include autoclaves, centrifuges, incubators, dry ovens, water and oil baths, biological safety cabinets, microscopes, tissue processors, balances, pH meters, conductivity meters, spectrophotometers, pipettes, refrigerators, and water purification systems. Additional offerings include microtomes, oscillators, polarimeters, clean benches, ultrasonic water baths, water distillers, and PRP (platelet-rich plasma) processing equipment. Aiken provides customer service Monday–Friday, 8:30 am–5 pm PST, including technical support, field service, maintenance, repair, and troubleshooting. The company emphasizes equipment reliability, operational performance, and total cost reduction for laboratory operations. Distribution is global, with manufacturing networks serving domestic and international markets.

Alpha Omega Engineering Ltd. is a specialized neuroscience and neurosurgery technology company developing advanced systems for neurophysiology research, deep brain stimulation (DBS) procedures, and clinical applications. The company manufactures microelectrode recording (MER) systems, brain mapping software, and DBS navigation tools used in human, primate, and rodent research settings, as well as in clinical neurosurgery and functional neurology. Their product portfolio includes portable and stationary MER systems with target localization capabilities, motorized commutators for free-moving animal studies, and neurological patient management platforms. Alpha Omega serves research institutions, neurosurgical centers, and clinical research organizations globally, supporting thousands of DBS procedures annually. The company emphasizes engineering precision, data reliability, and repeatability in neurophysiological signal acquisition. Their clinical research solutions integrate sophisticated hardware and software for brain mapping in both awake and asleep DBS procedures for the treatment of movement disorders and psychiatric conditions. Alpha Omega provides comprehensive customer support, technical engineering assistance, and training to optimize system implementation and clinical outcomes.

Spectrum Fertility Genomics is a leading provider of cutting-edge solutions for In Vitro Fertilization (IVF) and reproductive genomics. The company specializes in epigenomic innovation and genetic analysis tools designed to support fertility clinics, reproductive laboratories, and healthcare professionals. Their product portfolio includes preimplantation genetic diagnostic (PGD) kits and DNA methylation detection assays used in IVF embryo screening and selection. The company positions itself as a trusted partner for assisted reproductive technology (ART) providers, offering molecular diagnostic solutions that help improve fertility outcomes by enabling genomic profiling of embryos prior to implantation. Spectrum Fertility Genomics maintains strategic partnerships with international life science companies and actively participates in professional conferences including the American Society for Reproductive Medicine (ASRM) and the Preimplantation Genetic Diagnosis International Society (PGDIS), indicating alignment with clinical and regulatory standards in the reproductive medicine field.

Digitimer North America, LLC is the exclusive importer and distributor of Digitimer Ltd. (UK) products for the USA, Canada, and Mexico. Digitimer Ltd. has over 50 years of experience designing and manufacturing electronic instrumentation for medical researchers, practitioners, laboratories, hospitals, and universities. The company specializes in precision measurement and stimulation devices for research and clinical applications. Product lines include human physiology and research instrumentation, animal and cellular tissue research equipment, pediatric surgery devices, and brain tissue preservation systems (brain slice chambers and keepers). Their portfolio comprises extracellular amplifiers, mains noise eliminators, and specialized electrophysiology equipment. Digitimer is recognized for producing reliable, high-quality electronic instrumentation with an established reputation in academic medical centers, including endorsement from Harvard Medical School. The company serves the research community across neuroscience, physiology, pediatric surgery, and cellular biology disciplines. Products are designed to meet the precision requirements of laboratory and clinical settings, with emphasis on signal integrity and measurement accuracy.

Cenogenics Corporation is an FDA-registered, ISO 13485:2016-certified manufacturer and marketer of high-quality diagnostic kits and reagents for clinical and professional applications. The company specializes in in vitro diagnostic (IVD) products including stool occult blood tests, febrile (Widal) antigens, colorectal cancer screening assays, Lyme disease serology, syphilis detection kits, and veterinary diagnostic test kits. The company offers complete private-label branding and contract manufacturing services, enabling partners to formulate and package diagnostic products tailored to their specifications. Cenogenics' manufacturing heritage includes Laboratory Diagnostics Company, among the earliest developers of guaiac occult blood slides, with their occult blood tests now used globally for early detection of colorectal cancer indicators. The company emphasizes consistent quality, ease of readability, competitive pricing, and optimized reactivity and sensitivity in all products. Services include private labeling, contract manufacturing, joint ventures, and distributor partnerships. Products are manufactured to international standards and supplied worldwide to clinical laboratories, healthcare providers, and diagnostic distributors.

Epitope Diagnostics Inc. is an ISO 13485:2016 certified and FDA-registered medical device manufacturer specializing in niche immunoassays for clinical diagnostics and research communities. Headquartered in San Diego, California, the company manufactures chemiluminescence immunoassay kits, automated ELISA kits, lateral flow rapid test kits (EPITUUB® US patented), and specialty antibodies. Product portfolios span tumor markers and cancer research, gastrointestinal disease diagnostics, infectious disease testing, cardiovascular disease markers, calcium and bone metabolism assays, endocrinology and diabetes testing, autoimmune disease panels, and anemia diagnostics. The company serves both USA and international markets through separate product catalogs and maintains automation and analyzer platforms alongside traditional immunoassay methodologies. All products are designed for professional laboratory use in clinical and research settings. The company maintains full regulatory compliance with FDA licensing and ISO quality management systems certification valid through June 2026.

Esco Lifesciences Group is a world-leading manufacturer of laboratory and biopharma equipment, biological safety cabinets, and IVF medical devices, headquartered in Singapore since 1978. The company serves over 100 countries with a diversified portfolio spanning clinical diagnostics, pharmaceutical manufacturing, bioprocessing, and assisted reproductive technology (ART). Core product lines include CO₂ incubators (CelCulture® Touch series), temperature-controlled shakers (OrbiCult™), biosafety cabinets, fume hoods (Frontier Duo series), PCR cabinets, ultra-low freezers, and cryogenic storage systems. Esco also operates Esco Aster, a CDMO providing contract manufacturing and process development services across upstream/downstream bioprocessing, formulation, and filling. The company employs over 1,700 staff across multiple R&D and manufacturing sites, offering comprehensive support including installation, certification, training, maintenance, and decommissioning services. Applications span pharmaceutical QC, clinical diagnostics, food microbiology, cell therapy, gene therapy, medical device assembly, and biocontainment for BSL-3/4 research.

INCELL Corporation LLC is a GMP (Good Manufacturing Practice) contract manufacturer and services provider headquartered in San Antonio, Texas. The company specializes in research, development, manufacturing, and cryostorage of cells, tissues, and support products for regenerative medicine applications. INCELL operates as both a manufacturer of proprietary cell culture media, collection and transport solutions, and cryopreservation media, and as a service provider offering cell and tissue culture, banking, and testing services. The company serves research institutions, clinical laboratories, and therapeutic development partners. INCELL manufactures branded product lines including M3™ and M4™ culture media families, EZ-CPZ™ cryopreservation media, collection and transport solutions (ZTM series), processing buffers (ZSol-F™), and RBC lysing buffers (ZAPR™). The company also develops and supplies proprietary cell lines, including monoclonal antibody-producing hybridoma lines and specialized cell lines (NCM460D, NCM356D). In addition to manufacturing, INCELL provides contract manufacturing services for regenerative medicine therapies, microbiology diagnostics and therapeutics, personalized medicine approaches (including patient tumor culture and cryostorage for cancer patients), and clinical trial support through its subsidiary 4RMED LLC. The company's regulatory expertise and manufacturing capabilities align with FDA oversight of human cells and tissues products. INCELL holds GMP certification and operates under standards applicable to cell and tissue manufacturing. The company serves pharmaceutical, biotechnology, academic research, and hospital laboratory markets, with notable focus on regenerative medicine and cell therapy development, including involvement in ALS cell therapy clinical applications.

Diagnomatic is a healthcare technology company specializing in automated quality assurance (QA) solutions for medical imaging equipment. Operating as a division of Pro-Project (Poland), Diagnomatic combines intelligent software platforms, benchmarking test phantoms, and cloud-based processing to enhance diagnostic accuracy and ensure regulatory compliance across multiple imaging modalities. The company's integrated QA platform supports CT, MRI, mammography, radiography, fluoroscopy, ultrasound, nuclear medicine, and radiotherapy equipment. Core offerings include automated image scoring with instant failure alerts, enterprise-grade software with audit-ready reporting, ACR-approved test phantoms, and flexible cloud or on-premise deployment options. Diagnomatic holds ISO 9001, 13485, 14001, 27001, and 45001 certifications, with endorsements from major OEMs (GE, Siemens, Philips, Toshiba, Canon, FujiFilm) and leading hospital networks. The platform significantly reduces QA testing time, minimizes downtime, facilitates team collaboration, and accelerates accreditation readiness.

KSL Diagnostics is a national reference laboratory headquartered outside Buffalo, New York, specializing in CLIA-certified and CAP-accredited cytogenetic diagnostic testing. The company focuses on comprehensive chromosome abnormality analysis for oncology and acquired genetic disorders, serving pathologists and clinicians across the United States. KSL Diagnostics operates a state-of-the-art facility with a team of highly qualified clinical professionals possessing over 75 years of combined clinical service experience. The organization employs a consultative approach to guide physicians through a comprehensive testing menu, supporting precision medicine initiatives and improved patient outcomes. Strategic partnerships, including affiliation with University at Buffalo and Thermo Fisher Scientific, enhance KSL's diagnostic capabilities and service offerings. The company's core competencies include cytogenetic analysis, chromosome disorder diagnosis, and reference laboratory services. Leadership is composed of industry experts committed to quality assurance, customer service, and solutions-driven laboratory operations. KSL Diagnostics operates under three guiding principles: Excellence, Innovation, and Growth.

Parasol Medical LLC is a specialty medical device manufacturer focusing on innovative solutions across patient safety, infection control, advanced wound care, and life science applications. The company develops products designed to improve clinical workflows and patient outcomes in healthcare settings. Key product lines include Parasol™ Fall Prevention systems for preventing patient falls, drysmart™ technology for wound care and infection control applications, Tone™ Antimicrobial Stethoscopes featuring MicrobeCare™ persistent antimicrobial coating, Cultivate™ for aseptic practices and quality control, Remora™ for advanced wound management, and Microbecare™ antimicrobial solutions. The company has demonstrated innovation recognition, winning first place in MedAssets' New Emerging Technology Forum among over 500 medical device manufacturers. Parasol Medical serves healthcare facilities with emphasis on infection prevention, patient safety protocols, and sterile compounding compliance (USP <797> and <800>). The company provides educational resources and technical guidance on viable air/surface sampling, wipe sampling for hazardous drugs, and best practices for maintaining sterile compounding environments. Products are available through both direct sales and online shopping platforms.

SARSTEDT AG & Co. KG is a global manufacturer and distributor of laboratory consumables and sample-handling products for clinical diagnostics, life science research, and laboratory automation. The company operates four primary business divisions: preanalytics (blood, urine, fecal, and saliva collection systems and accessories), life science (liquid handling, cell culture, molecular biology, sample handling, and microbiology products), sample transport (diagnostic sample containers compliant with ADR/RID and IATA dangerous goods regulations), and laboratory automation (modular automation solutions for diagnostic laboratories with over 25 years of development experience). SARSTEDT's product portfolio includes screw-cap micro tubes (0.5–2.0 ml), reagent and centrifuge tubes, serological pipettes, micro test plates, cell culture flasks, Monovette® blood collection tubes, Microvette® capillary collection devices, and Urine Monovette® collection systems. Products are manufactured to stringent quality standards, certified as sterile, non-pyrogenic, endotoxin-free, non-cytotoxic, and free from DNA/DNase/RNase contamination. The company maintains over 13 production facilities and 30 sales organizations worldwide. SARSTEDT serves clinical laboratories, medical practices, research institutions, and diagnostic facilities. The company emphasizes user-focused design, safety, reproducibility, and compliance with international regulatory requirements.

Newcomer Supply Inc manufactures and supplies laboratory reagents, controls, and consumables for clinical pathology, histology, and diagnostic testing. The company specializes in histology and pathology reagents, including staining reagents (Schiff's Reagent for carbohydrate detection), transport media for specimen preservation (Michel Transport Medium), and quality control materials for immunohistochemistry and specialized pathology applications. Product offerings include Pap GnomePen (a liquid blocking pen for cytology slides), PD-L1 analyte control materials for immunohistochemistry validation, and amyloid control slides for standardized pathology testing. These consumables support laboratory workflows in hospitals, diagnostic centers, and research institutions performing histological analysis, immunohistochemistry, and cytopathology. The company serves clinical laboratory and pathology markets with reagents, controls, and accessories that enable accurate specimen preparation, staining, and quality assurance in anatomic pathology.

IUL SA, founded in 1987, designs, manufactures, and markets microbiological control instruments and diagnostic devices serving laboratory, food safety, pharmaceutical, and environmental monitoring sectors. The company operates three primary divisions: IUL Micro (classical microbiology lab automation and consumables), MedIUL (lateral flow test readers for in-vitro diagnostics), and OEM (original equipment manufacturer services). Core product lines include automated colony counting and spiraling systems, air samplers (EN 17141/2020 compliant), and lateral flow reader platforms. Key innovations include the SphereFlash® AI colony counting software (AI-powered automated image analysis), iPeak® Europium and iPeak® Plus lateral flow readers for fluorescence and colorimetric assays, the Eddy Jet 2W spiral plater for rapid culture plating, and Spin Air high-biocollection efficiency samplers for environmental microbiology. All instruments are designed with original patents and engineered for reduced turnaround time in microbiology testing workflows. The company recently expanded internationally with U.S. headquarters established in 2025 and German operations (IUL GmbH), indicating growth in North American and European markets. Serves pharmaceutical QA/QC, food safety, clinical microbiology, and environmental monitoring laboratories.